These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12893407)

  • 1. Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy.
    Jabr FI; Ordinario MM
    Am J Med; 2003 Aug; 115(2):158-9. PubMed ID: 12893407
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.
    Soultati AS; Dourakis SP; Alexopoulou A; Deutsch M; Archimandritis AJ
    World J Gastroenterol; 2007 Feb; 13(8):1292-4. PubMed ID: 17451219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pegylated interferon alfa-induced psoriasis].
    González-López MA; González-Vela MC; López-Escobar M; Fernando Val-Bernal J
    Med Clin (Barc); 2007 Sep; 129(9):358. PubMed ID: 17910858
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 5. [Healing hepatitis C infections. Pegylated interferon alfa-2a opens new perspectives].
    MMW Fortschr Med; 2003 Jun; 145(26):52-3. PubMed ID: 12916339
    [No Abstract]   [Full Text] [Related]  

  • 6. A rare complication of pegylated interferon Alfa 2a in a hepatitis C-positive patient on maintenance hemodialysis.
    Satish R; ; Mathew T
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):139-42. PubMed ID: 22237239
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombotic microangiopathy complicating pegylated interferon treatment of hepatitis C infection.
    Iskander D; Wickremasinghe M; Bain BJ
    Am J Hematol; 2011 Oct; 86(10):859. PubMed ID: 21630311
    [No Abstract]   [Full Text] [Related]  

  • 8. Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy.
    Jensen SL; Holmes R
    J Drugs Dermatol; 2003 Oct; 2(5):554-6. PubMed ID: 14558405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pericardial effusion associated with interferon therapy].
    Cervera Miguel JI; Vallalta M; Iranzo E; Navarro Ibáñez V
    Med Clin (Barc); 2004 May; 122(16):636-7. PubMed ID: 15142514
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2b and ribavirin for recurrent hepatitis C.
    Mukherjee S
    J Gastroenterol Hepatol; 2004 Jun; 19(6):723-4. PubMed ID: 15151639
    [No Abstract]   [Full Text] [Related]  

  • 11. Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C.
    Jen JF; Glue P; Ezzet F; Chung C; Gupta SK; Jacobs S; Hajian G
    Clin Pharmacol Ther; 2001 Jun; 69(6):407-21. PubMed ID: 11406738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated interferon and ribavirin therapy for hepatitis C causing cataract.
    Ku JY; Sharma A
    Clin Exp Ophthalmol; 2009 Sep; 37(7):743-5. PubMed ID: 19788675
    [No Abstract]   [Full Text] [Related]  

  • 13. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation.
    Kontorinis N; Agarwal K; Elhajj N; Fiel MI; Schiano TD
    Liver Transpl; 2006 May; 12(5):827-30. PubMed ID: 16628699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized interstitial granuloma annulare induced by pegylated interferon-alpha.
    Kluger N; Moguelet P; Chaslin-Ferbus D; Khosrotherani K; Aractingi S
    Dermatology; 2006; 213(3):248-9. PubMed ID: 17033180
    [No Abstract]   [Full Text] [Related]  

  • 15. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
    Quinn D; Kuchler E; Deming P; Arora S
    Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
    [No Abstract]   [Full Text] [Related]  

  • 16. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
    Lee YN; Jeong SW; Lim JH; Ryu YS; Jeon SR; Kim SK; Jang JY; Kim YS; Kim BS; Roh MO
    Korean J Hepatol; 2010 Jun; 16(2):187-91. PubMed ID: 20606504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS.
    Abi-Nassif S; Mark EJ; Fogel RB; Hallisey RK
    Chest; 2003 Jul; 124(1):406-10. PubMed ID: 12853555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus treatment with pegylated interferon-alfa therapy leading to generalized interstitial granuloma annulare and review of the literature.
    Ahmad U; Li X; Sodeman T; Daboul I
    Am J Ther; 2013; 20(5):585-7. PubMed ID: 21317616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral nervous system involvement in a haemodialysis patient treated with pegylated interferon.
    Ruiz-Fuentes MC; Rubert-Gómez De Quero A; De Gracia-Guindo C; Galindo-Sacristán P; Osuna-Ortega A
    Nefrologia; 2012; 32(6):863-5. PubMed ID: 23169385
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapidly reversible increase in insulin requirement with interferon.
    Campbell S; Mclaren EH; Danesh BJ
    BMJ; 1996 Jul; 313(7049):92. PubMed ID: 8688762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.